Initiative / InterLACE

International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events

International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events

InterLACE logo
Studies 0
The aim of InterLACE is to advance understandingof women’s reproductive health in relation to chronic disease risk by pooling individual participant data from several cohort and cross-sectional studies.
Visit InterLACE

Members

Investigators Contacts
  • Prof. Gita Mishra
    The University of Queensland School of Public Health

General Information

Year created
2012
Types of cohorts
  • Population cohort
Countries
  • Australia
  • United Kingdom
  • Denmark
  • France
  • Japan
  • United States of America
  • Lebanon
  • Spain
  • Sweden
  • Morocco
  • China
Setting
International
Funding
This project has received funding from the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC).
Criteria of cohort's to be included
Observational studies, which had collected prospective or retrospective survey data on women’s reproductive health across the lifespan (such as ages at menarche, first birth, and natural menopause), sociodemographic and lifestyle factors, and chronic disease events, could contribute data to the InterLACE consortium, regardless of the sample size and ethnic background of participants.
Socio-environmental context
  • NA

Participants

Number of participants

Total
839,666
With harmonized data
839,666

Age range of the samples

Minimum age
30
Maximum age
75

Methodology for harmonization and integration

Strategy of harmonization
Ex-post
Data processing methods
  • NA
  • Type of infrastructure
    Data are centrally located
    Integrative data analysis
    • Pooled analyses
    Software
  • SAS
  • Supplementary information
    Mishra G et al. The InterLACE study: Design, data harmonization and characteristicsacross 20 studies on women’s health. Maturitas 92 (2016) 176–185. doi:10.1016/j.maturitas.2016.07.021

    Number of cohorts

    Total
    26
    With harmonized data
    26
    Will more cohorts be harmonized?
    Number of harmonized variables (max.)
    1,300

    Access

    Availability of metadata
    Availability of individual data